Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04623502 · ClinicalTrials.gov registry record · NA
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
A NA study of Renal Cell Carcinoma and Urothelial Carcinoma, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT04623502 is a NA study of Renal Cell Carcinoma and Urothelial Carcinoma that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 600 participants, above the 238-participant average among 121 other Renal Cell Carcinoma trials with a reported enrollment target (152% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04623502, a NA study of Renal Cell Carcinoma and Urothelial Carcinoma, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand the metabolism of cancers involving the kidney, including renal cell carcinomas and urothelial cell carcinomas, and how kidney cancers use different types of fuel to support tumor growth. This study uses specially labeled nutrient tracers of compounds normally found circulating in the blood. The nutrients (glucose, fructose, glutamine, acetate, and lactate) are also found in common foods. A nutrient tracer will be given to the participants through an intravenous (IV) catheter during surgery or biopsy, and blood will be collected every 30 minutes during the infusion to monitor safety parameters and the nutrient tracers. The investigators will collect a tissue sample after the completion of surgery. Participants not having an infusion will have their tissue collected after surgery or biopsy. Participation in this study will not change patient care. All patients will receive standard of care treatment as determined by their doctors.
Conditions Studied
Interventions
- OTHER 13C-Glucose
- OTHER 13C-Acetate
- OTHER 13C-Lactate
- OTHER 13C-Glutamine
- OTHER 13C-Fructose
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2019-09-30 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04623502
The ClinicalTrials.gov registry entry for NCT04623502 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 238-participant average among 121 other Renal Cell Carcinoma trials with a reported enrollment target (152% higher). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Renal Cell Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which 13C-Glucose is the first listed.
NCT04623502 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04623502 about?
NCT04623502 is a clinical study titled "An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy". The purpose of this study is to understand the metabolism of cancers involving the kidney, including renal cell carcinomas and urothelial cell carcinomas, and how kidney cancers use different types of fuel to support tumor growth. This study uses specially labeled nutrient tracers of compounds norma...
What is the current status of trial NCT04623502?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2019-09-30. Estimated completion is 2027-09-30.
What conditions does trial NCT04623502 study?
This clinical trial studies the following conditions: Renal Cell Carcinoma, Urothelial Carcinoma, Kidney Cancer, Metastatic Urothelial Carcinoma, Chromophobe Renal Cell Carcinoma.
What interventions are being tested in trial NCT04623502?
The interventions under investigation include: 13C-Glucose (OTHER), 13C-Acetate (OTHER), 13C-Lactate (OTHER), 13C-Glutamine (OTHER), 13C-Fructose (OTHER).
Who is sponsoring clinical trial NCT04623502?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04623502 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)
RECRUITING · NA
-
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
RECRUITING · NA
-
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
RECRUITING · NA
-
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
RECRUITING · NA
-
Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy
RECRUITING · NA
-
Evaluation of a Simple-Prep Controlled Embolic
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.